Inspire Medical Systems, Inc. Common Stock (INSP)
87.91
-42.04 (-32.35%)
NYSE · Last Trade: Aug 6th, 2:45 AM EDT
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.
Via Chartmill · August 5, 2025
Via Benzinga · August 5, 2025
Inspire Medical stock falls as Q2 earnings beat is overshadowed by guidance cut and slower U.S. rollout of its newly approved Inspire V system.
Via Benzinga · August 5, 2025
Inspire Medical Systems Stock Slumps On Downgrades, Price Target Cuts: Retail Believes Stock Is Way Oversoldstocktwits.com
Via Stocktwits · August 5, 2025
Shares of medical technology company Inspire Medical Systems (NYSE:INSP)
fell 41.3% in the afternoon session after the company slashed its full-year revenue and profit forecasts, a move that overshadowed a second-quarter earnings beat.
Via StockStory · August 5, 2025
Via Benzinga · August 5, 2025
Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · August 5, 2025
Let's have a look at the gap up and gap down stocks in today's session.
Via Chartmill · August 5, 2025
The company makes implantable devices for sleep apnea, an area Eli Lilly is marketing its weight-loss drug.
Via Investor's Business Daily · August 5, 2025
Via Benzinga · August 5, 2025
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · August 5, 2025
Via Benzinga · August 5, 2025
Via Benzinga · August 5, 2025
Via Benzinga · August 5, 2025
Medical technology company Inspire Medical Systems (NYSE:INSP) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 10.8% year on year to $217.1 million. On the other hand, the company’s full-year revenue guidance of $905 million at the midpoint came in 4.6% below analysts’ estimates. Its GAAP loss of $0.12 per share was significantly below analysts’ consensus estimates.
Via StockStory · August 4, 2025
Via Benzinga · August 4, 2025
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · August 4, 2025
Inspire Medical Systems (NYSE:INSP) offers strong growth, fair valuation, and solid financial health, making it an ideal pick for affordable growth investors.
Via Chartmill · August 4, 2025
Medical technology company Inspire Medical Systems (NYSE:INSP)
will be reporting earnings this Monday after the bell. Here’s what to expect.
Via StockStory · August 2, 2025
Via Benzinga · August 1, 2025
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Via StockStory · August 1, 2025